Artykuły udostępnione publicznie: - Paul BieniaszWięcej informacji
Niedostępne w żadnym miejscu: 4
Multiple, switchable protein: RNA interactions regulate human immunodeficiency virus type 1 assembly
P Bieniasz, A Telesnitsky
Annual review of virology 5 (1), 165-183, 2018
Upoważnienia: US National Institutes of Health
An overview of intracellular interactions between immunodeficiency viruses and their hosts
PD Bieniasz
Aids 26 (10), 1243-1254, 2012
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute
Therapeutic neutralizing monoclonal antibodies: report of a summit sponsored by operation warp speed and the national institutes of health
FS Collins, J Woodcock, BS Graham, A Arvin, P Bieniasz, D Ho, G Alter, ...
BioRxiv 2, 2, 2020
Upoważnienia: Bill & Melinda Gates Foundation, US National Institutes of Health
135 Tetherin-Keeping Virions on a Leash
PD Bieniasz
JAIDS Journal of Acquired Immune Deficiency Syndromes 59, 56, 2012
Upoważnienia: US National Institutes of Health
Dostępne w jakimś miejscu: 168
A diverse range of gene products are effectors of the type I interferon antiviral response
JW Schoggins, SJ Wilson, M Panis, MY Murphy, CT Jones, P Bieniasz, ...
Nature 472 (7344), 481-485, 2011
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
DF Robbiani, C Gaebler, F Muecksch, JCC Lorenzi, Z Wang, A Cho, ...
Nature 584 (7821), 437-442, 2020
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute, Chan …
Evolution of antibody immunity to SARS-CoV-2
C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ...
Nature 591 (7851), 639-644, 2021
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute, Wellcome …
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
MJ Evans, T von Hahn, DM Tscherne, AJ Syder, M Panis, B Wölk, ...
Nature 446 (7137), 801-805, 2007
Upoważnienia: German Research Foundation
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Z Wang, F Schmidt, Y Weisblum, F Muecksch, CO Barnes, S Finkin, ...
Nature 592 (7855), 616-622, 2021
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute, Wellcome …
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Y Weisblum, F Schmidt, F Zhang, J DaSilva, D Poston, JCC Lorenzi, ...
elife 9, e61312, 2020
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies
CO Barnes, AP West, KE Huey-Tubman, MAG Hoffmann, NG Sharaf, ...
Cell 182 (4), 828-842. e16, 2020
Upoważnienia: US Department of Energy, Bill & Melinda Gates Foundation, US National …
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Z Wang, F Muecksch, D Schaefer-Babajew, S Finkin, C Viant, C Gaebler, ...
Nature 595 (7867), 426-431, 2021
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute, Wellcome …
Vaccine breakthrough infections with SARS-CoV-2 variants
E Hacisuleyman, C Hale, Y Saito, NE Blachere, M Bergh, EG Conlon, ...
New England Journal of Medicine 384 (23), 2212-2218, 2021
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute
Tetherin inhibits HIV-1 release by directly tethering virions to cells
D Perez-Caballero, T Zang, A Ebrahimi, MW McNatt, DA Gregory, ...
Cell 139 (3), 499-511, 2009
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute
HIV restriction factors and mechanisms of evasion
MH Malim, PD Bieniasz
Cold Spring Harbor perspectives in medicine 2 (5), a006940, 2012
Upoważnienia: US National Institutes of Health
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
F Schmidt, Y Weisblum, F Muecksch, HH Hoffmann, E Michailidis, ...
Journal of Experimental Medicine 217 (11), 2020
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
F Klein, A Halper-Stromberg, JA Horwitz, H Gruell, JF Scheid, ...
Nature 492 (7427), 118-122, 2012
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute, German …
MX2 is an interferon-induced inhibitor of HIV-1 infection
M Kane, SS Yadav, J Bitzegeio, SB Kutluay, T Zang, SJ Wilson, ...
Nature 502 (7472), 563-566, 2013
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute, UK …
Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains
D Sauter, M Schindler, A Specht, WN Landford, J Münch, KA Kim, ...
Cell host & microbe 6 (5), 409-421, 2009
Upoważnienia: US National Institutes of Health, German Research Foundation
Plasma neutralization of the SARS-CoV-2 Omicron variant
F Schmidt, F Muecksch, Y Weisblum, J Da Silva, E Bednarski, A Cho, ...
New England Journal of Medicine 386 (6), 599-601, 2022
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy